logo

For the Inventor, By the Inventor

London, United Kingdom

Gyroscope Therapeutics Limited

Calculating rank
USPTO Granted Patents = 17



Trademarks = 5

Forward Citations = 23

Loading Chart...
Loading Chart...

36 inventors (with patents filed for the assignee):

goldMedal Michael F Keane (13 out of 32 patents)

silverMedal Benjamin L Ko (12 out of 20 patents)

bronzeMedal Isaac John Khan (12 out of 30 patents)

4.  Brendan J Oberkircher (11 out of 44 patents)

5.  Thomas Edward Meyer (10 out of 89 patents)

6.  Daniel W Price (9 out of 142 patents)

7.  Mark C Tsai (4 out of 9 patents)

8.  Geoffrey King (4 out of 5 patents)

9.  Daniel James Prenger (4 out of 18 patents)

10.  Robert H Roth (4 out of 46 patents)

11.  Michel Bruehwiler (3 out of 80 patents)

12.  Nathan Daniel Grubbs (3 out of 36 patents)

13.  Saeed Sokhanvar (3 out of 20 patents)

14.  Daniel J Yasevac (3 out of 17 patents)

15.  Leah R Soffer (3 out of 7 patents)


17 patents:

1. 12728171 - COMPLEMENT FACTOR I AND COMPLEMENT FACTOR I COFACTOR, VECTORS ENCODING THEREFOR AND THERAPEUTIC USE (2026-09-08),
2. 12083042 - Guide apparatus for tangential entry into suprachoroidal space (2024-09-10),
3. 11998482 - Method and apparatus for subretinal administration of therapeutic agent (2024-06-04),
4. 11771834 - Dose clip assembly for syringe (2023-10-03),
5. 11759355 - Method of delivering leading blebs and agent to subretinal space (2023-09-19),
6. 11723798 - Sub-retinal tangential needle catheter guide and introducer (2023-08-15),
7. 11672696 - Therapeutic agent delivery device with convergent lumen (2023-06-13),
8. 11554042 - Method and apparatus for subretinal administration of therapeutic agent (2023-01-17),
9. 11338084 - Apparatus for subretinal administration of therapeutic agent via a curved needle (2022-05-24),
10. 11337852 - Therapeutic agent delivery device (2022-05-24),
11. 11273072 - Suprachoroidal injection device (2022-03-15),
12. 11076984 - Method of performing subretinal drainage and agent delivery (2021-08-03),
13. 11058576 - Method and apparatus for subretinal administration of therapeutic agent (2021-07-13),
14. 11000410 - Guide apparatus for tangential entry into suprachoroidal space (2021-05-11),
15. 10821021 - Sub-retinal tangential needle catheter guide and introducer (2020-11-03),
Company Overview
Gyroscope Therapeutics Limited is a biotechnology company based in London, specializing in gene therapy for the treatment of eye diseases. The organization focuses on developing innovative therapies aimed at addressing significant unmet medical needs in ophthalmology. Gyroscope is dedicated to advancing its proprietary gene therapy platform, which leverages cutting-edge research to create transformative treatments that can improve patient outcomes and quality of life. The company is committed to pioneering advancements in the field of retinal diseases.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

17 Patents

#215 in London

#1,062 in United Kingdom

#36,017 in the World

London, GB
London, United Kingdom

Gyroscope Therapeutics Limited

Forward Citations = 23

36 inventors:

goldMedal Michael F Keane (13 out of 32 patents)

silverMedal Benjamin L Ko (12 out of 20 patents)

bronzeMedal Isaac John Khan (12 out of 30 patents)

4.  Brendan J Oberkircher (11 out of 44 patents)

5.  Thomas Edward Meyer (10 out of 89 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gyroscope Therapeutics Limited. Retrieved from https://idiyas.com/company/gyroscope-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…